Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Lion Biotechnologies (LBIO)

Lion Biotechnologies (LBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Financial Summary for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Lion Biotechnologies, Inc. is developing autologous cell therapies for the treatment of cancer. The Company's lead product candidate, C'ntego(TM), is an autologous cell therapy indicated for the treatment of metastatic melanoma. Lion Biotechnologies, Inc., formerly known as Genesis Biopharma, Inc., is based in Woodland Hills, California.

Income Statement

(Values in U.S. Thousands) Mar, 2017 Dec, 2016 Sep, 2016 Jun, 2016 Mar, 2016
Sales 0 0 0 0 0
Sales Growth unch unch unch unch unch
Net Income -20,680 -15,690 -18,760 -11,560 -6,880
Net Income Growth -31.80% +16.36% -62.28% -68.02% +17.70%

Balance Sheet

(Values in U.S. Thousands) Mar, 2017 Dec, 2016 Sep, 2016 Jun, 2016 Mar, 2016
Total Assets 155,390 171,890 182,330 193,540 100,770
Total Assets Growth -9.60% -5.73% -5.79% +92.06% -4.62%
Total Liabilities 5,500 4,970 3,190 4,610 1,830
Total Liabilities Growth +10.66% +55.80% -30.80% +151.91% +12.27%

Cash Flow

(Values in U.S. Thousands) Mar, 2017 Dec, 2016 Sep, 2016 Jun, 2016 Mar, 2016
Operating Cash Flow -18,800 -32,670 -20,510 -8,300 -4,550
Operating Cash Flow Growth +42.45% -59.29% -147.11% -82.42% +75.24%
Net Cash Flow 380 73,130 59,310 87,580 -4,700
Change in Net Cash Flow -99.48% +23.30% -32.28% +1,963.40% +84.97%
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot